Gacho, Rabie Nichel .
HRN: 09-44-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
CEFTRIAXONE 1G (VIAL)
08/02/2022
08/08/2022
IV
1g
Q12hrs
T/c Tetanus
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes